Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.
Low levels of some hormone receptors in patients with subclinical Cushing’s syndrome and in those with a type of adrenal gland tumor called pheochromocytoma, all with abnormal hormone levels ... Read more
Treatment with Signifor (pasireotide) for one year reduces the risk for heart disease and diabetes in patients with Cushing’s disease, by improving visceral adiposity index (VAI) scores and adipose tissue dysfunction, ... Read more
Using endoscopic or microscopic techniques to surgically remove the pituitary glands leads to similar remission and recurrence rates in Cushing’s disease patients, a review of 24 studies shows. The ... Read more
Stereotactic radiosurgery – a type of targeted, high-dose radiation therapy – delivered with CyberKnife technology effectively induces remission in Cushing’s disease patients whose condition persisted after surgical removal of their pituitary ... Read more
A long-acting, once-a-month treatment of Signifor (pasireotide) normalized cortisol levels in 40% of patients with Cushing’s disease whose disease had recurred after surgery, or who were not candidates for ... Read more
Researchers report a new technique for collecting blood samples from tiny veins of the adrenal glands, called super-selective adrenal venous sampling (ssAVS). The technique can be used to hep ... Read more
Pin It on Pinterest